The first-ever MQPH Conference will take place at Keble College, Oxford on 23-28 September 2018. This international event will bring together people from public health, national regulatory authorities, pharmacy, biomedical, chemistry, law, ethics, cultural and social sciences, pharmaceutical industry, international organisations and NGOs. It grants an opportunity to discuss the problem and outline the necessary steps to tackle the issue on a global scale. Pre-register your interest now!
6 July Bangkok – An existing malaria rapid diagnostic test (RDT) can be adapted to predict the delayed anaemia that can complicate severe malaria in patients treated with artemisinin-based antimalarial drugs, say researchers in a study published today in Science Translational Medicine Journal. “These findings are relevant to the thousands of ...
Researchers from Oxford University Clinical Research Unit in Vietnam have shown that amphotericin B is more effective than itraconazole for the initial treatment of talaromycosis in HIV patients. The principal investigator, Dr Thuy Le stated: “These results offer strong support to the call for more health policy and advocacy to improve access to amphotericin B across Asia. Implementation of the research findings is now needed in the region.”
How do you turn orange into grapefruit? What is digital wildfire? Is love real? Booking is now open for the Curiosity Carnival on Friday 29 September 2017, part of European Researchers' Night. Most of the event is free, but registration is required.
Mahosot Hospital has reopened its microbiology laboratory aiming to increase the more rapid and accurate diagnosis and treatment of its patients. The original microbiology laboratory finished construction in 1920 and was then extended in 2011. The latest renovations to the laboratory’s building were started on September 5, 2016 and finally ...
The KEMRI-Wellcome Trust research Programme seek to reach out to community members to empower them about the disease by creating awareness among affected populations.
It has been maintained for decades that quinine is the safest drug for treatment of malaria in the first trimester of pregnancy. In the largest analysis of data from Thailand and Africa, artemisinins are reported to be at least as safe as quinine. This will simplify treatment protocols worldwide.